Related Experiment Videos
What Did Not Work: The Drug or the Trial?
1Oklahoma Medical Research Foundation, Oklahoma City.
Arthritis & Rheumatology (Hoboken, N.J.)
|May 27, 2021
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Adiposity-Associated Monocyte Costimulatory Programming in Rheumatoid Arthritis Identified by Single-Cell Transcriptomics.
medRxiv : the preprint server for health sciences·2026
Disease diagnostics using machine learning of B cell and T cell receptor sequences.
Science (New York, N.Y.)·2025
Efficacy and Safety of Upadacitinib or Elsubrutinib Alone or in Combination for Patients With Systemic Lupus Erythematosus: A Phase 2 Randomized Controlled Trial.
Arthritis & rheumatology (Hoboken, N.J.)·2024
Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial.
Arthritis & rheumatology (Hoboken, N.J.)·2022
Disease diagnostics using machine learning of immune receptors.
bioRxiv : the preprint server for biology·2022
FSCN1 promotes rheumatoid arthritis progression via inhibiting TRIM38-mediated ubiquitination of IGF2BP1 in fibroblast-like synoviocytes.
Arthritis & rheumatology (Hoboken, N.J.)·2026
Risk of Cancer according to Duration of Targeted Therapy Exposure in Spondyloarthritis: A Nationwide Cohort Study from the French Health Insurance Database.
Arthritis & rheumatology (Hoboken, N.J.)·2026
Type I interferon drives dysfunction of a distinct CD8+ HLA-DRB1+ T cell subset in systemic lupus erythematosus.
Arthritis & rheumatology (Hoboken, N.J.)·2026
Anifrolumab Versus Belimumab for Cardiovascular Disease Risk in Systemic Lupus Erythematosus.
Arthritis & rheumatology (Hoboken, N.J.)·2026
Low Dose Radiation Therapy and Osteoarthritis Pain.
Arthritis & rheumatology (Hoboken, N.J.)·2026
Understanding non-medical prescribers' antimicrobial prescribing and stewardship competency: A scoping review.
Research in social & administrative pharmacy : RSAP·2026
False Friends in Fluorescence - Simple HPLC Evaluation of False Positive Fragment Hits in a DiFMUP Assay for Protein Tyrosine Phosphatase 1B.
Drug design, development and therapy·2026
Rebalancing innovation, affordability, and access for orphan drugs in the European Union.
The Lancet regional health. Europe·2026
Clinical and Economic Burden of Diseases with Accelerated Approval Therapies: Evidence of Unmet Patient Need.
Therapeutic innovation & regulatory science·2026